- Top-tier investor syndicate led by Matrix Capital, with participation from the Global Health Investment Corporation, Cercano Management, The Washington Research Foundation, Boom Capital Ventures, ...
Monod Bio, a biotechnology company focused on creating biosensors that can quickly and accurately diagnose diseases, has announced it raised $25 million in seed capital on August 15. The Seattle ...
SEATTLE and PALO ALTO, Calif., Dec. 3, 2025 /PRNewswire/ -- Monod Bio, a leader in computational protein design, and Gator Bio, a pioneer in biolayer interferometry (BLI) technologies, today announced ...
– Seasoned industry leader with over 20 years of experience joins as Monod Bio advances strategic growth and operational scaling Monod Bio is a Seattle-based biotechnology startup and a spinout from ...
Monod Bio co-founders, from left: David Shoultz, Daniel-Adriano Silva, and Alfredo Quijano Rubio. (Monod Photo) The news: Monod Bio raised $25 million to develop molecular biosensors that light up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results